Stocks and InvestingStocks and Investing
Mon, April 12, 2021
Fri, April 9, 2021
Thu, April 8, 2021
Wed, April 7, 2021
Tue, April 6, 2021

Matthew Harrison Maintained (AVIR) at Buy with Increased Target to $82 on, Apr 6th, 2021


Published on 2024-10-27 16:07:23 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Buy with Increased Target from $49 to $82 on, Apr 6th, 2021.

Matthew has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $66 on, Friday, January 29th, 2021